HNVR
Hanover Bancorp, Inc.
HNVR's fundamentals are mixed, but it looks expensive: trading at 16x earnings, above its usual 12x. Analysts expect strong earnings growth.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
HNVR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
HNVR's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like HNVR.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
HNVR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.7x | $9.35 | -58% |
| Forward | 7.9x | $22.23 | — |
| Fair | 11x | $16.03 | -28% |
| Current | 16x | $22.23 | — |
| Expensive | 17x | $24.34 | +9.5% |
Historical ranges are pointers, not guarantees.
HNVR's PE is in its expensive range at 16x. If earnings grow as analysts expect, today's price would be 7.9x next year's earnings, in its cheap range.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
HNVR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
HNVR has the edge over IREN on the outlook, with more favorable earnings expectations.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
HNVR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.81 | +101% |
| Q3 2026 | $1.40 | -7.9% |
| Q2 2026 | $1.27 | -17% |
| Q1 2026 | $1.05 | -20% |
| Q4 2025 | $1.00 | -40% |
| Q3 2025 | $1.52 | -7.9% |
| Q2 2025 | $1.53 | -7.3% |
| Q1 2025 | $1.31 | -33% |
| Q4 2024 | $1.66 | -9.8% |
HNVR has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
HNVR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $19.3M | +7.1% |
| Q2 2026 | $19.6M | +6.6% |
| Q1 2026 | $19.1M | +4.1% |
| Q4 2025 | $18.6M | +3.3% |
| Q3 2025 | $18M | +5.6% |
| Q2 2025 | $18.4M | +8.8% |
| Q1 2025 | $18.4M | +11% |
| Q4 2024 | $18M | +13% |
HNVR's revenue has grown year over year for 11 quarters in a row: $19M last quarter, up 7.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | +4.1 points |
| Q2 2026 | 28% | +9.3 points |
| Q1 2026 | 16% | +5.9 points |
| Q4 2025 | 0.7% | -28 points |
| Q3 2025 | 26% | -1.1 points |
| Q2 2025 | 18% | +12 points |
| Q1 2025 | 9.6% | -23 points |
| Q4 2024 | 29% | -2.8 points |
HNVR has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
HNVR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $14.7M | +504% |
| Q2 2026 | $18M | +$20.2M |
| Q1 2026 | -$2.7M | -169% |
| Q4 2025 | $8M | +278% |
| Q3 2025 | $2.4M | +18% |
| Q2 2025 | -$2.2M | +$708K |
| Q1 2025 | $3.9M | +18% |
| Q4 2024 | $2.1M | -44% |
HNVR has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
HNVR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.5% | -106K shares |
| 1 year | -2.3% | -165K shares |
| 3 years | -0.1% | -6.1K shares |
| 5 years | +50% | +2.4M shares |
HNVR has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $2.2M |
| Q4 2025 | $1.3M |
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
HNVR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.8x | Very low |
| Q1 2026 | -1.2x | Net Cash |
| Q4 2025 | 1.5x | Healthy |
| Q3 2025 | 3.5x | Elevated |
| Q2 2025 | 4.5x | High |
| Q1 2025 | 5.4x | High |
| Q4 2024 | 4.2x | High |
HNVR's net debt is less than a year of its operating earnings (EBITDA), down from 3.5 years a year ago. Net leverage isn't a meaningful measure for financial services companies like HNVR.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
HNVR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.8 | Neutral |
| Stochastic | 21.6 | Neutral |
HNVR's weekly RSI is 36 (neutral) and its Stochastic is 22 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
HNVR PE vs Financial Services Sector
| Metric | HNVR | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 13x | 22% above |
| PE % | 78 | 60 | 18 pts above |
HNVR is trading at 16x earnings, a 22% premium to the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
HNVR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $24.0 | 7.4% below |
| 20 week MA | $25.2 | 12% below |
| 50 week MA | $23.7 | 6.3% below |
| 100 week MA | $23.1 | 3.8% below |
| 200 week MA | $20.6 | 8% above |
HNVR has fallen below most of its moving averages, though it's still 8% above its 200-week average.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
HNVR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $21.5 | $19.9 | -7.8% |
| 2023 | $19.9 | $17.6 | -11% |
| 2024 | $17.6 | $22.4 | +27% |
| 2025 | $22.4 | $23.4 | +4.7% |
| 2026 YTD | $23.4 | $22.2 | -5% |
HNVR has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.